华体汇官网

Current Position:Home > News> Company News

Fully carry out school-enterprise cooperation to develop nucleic acid drugs

Writer: SEKSUN Release date:2022-08-02 View:62

On December 30, 2020, Harbin Pharmaceutical (Beijing) Biotechnology Co., Ltd. and Peking University Medical Department held a signing ceremony to establish the "Peking University Medicine Harbin Pharmaceutical Nucleic Acid Drug Collaborative Innovation Laboratory" and formally establish a strategic partnership.


In recent years, the value and potential of nucleic acid drugs have attracted attention in the global pharmaceutical field, and the nucleic acid drug industry has entered a stage of rapid development. Such drugs may bring revolutionary changes to the treatment of diseases, especially chronic diseases in the future. Peking University Medicine has been deeply involved in the field of nucleic acid drugs for many years, and has accumulated rich experimental experience and a solid scientific research foundation. Harbin Pharmaceutical is the first listed company in China's pharmaceutical industry. In view of the broad market application prospects of nucleic acid drugs, Peking University Medicine and Harbin Pharmaceutical have reached a consensus to carry out strategic cooperation and jointly work on the research and development of nucleic acid innovative drugs.


The "Collaborative Innovation Laboratory" is mainly engaged in the scientific research of nucleic acid drugs and related pharmaceutical products in the fields of anti-tumor, anti-viral and genetic diseases. The "laboratory" will make full use of the industrialization advantages of enterprises and the scientific research advantages of universities to carry out school-enterprise cooperation in an all-round way. Take the "laboratory" as the base for both industrial R&D and talent training. Relying on the "laboratory", the two parties will lay the foundation for further application for the National Major Project Fund.


Peking University School of Medicine is the first western medical school founded by the Chinese government, and one of the first institutions of higher learning to be constructed under the national "211 Project". part of the discipline. After joining with Peking University in 2000, the Faculty of Medicine has made full use of the comprehensive discipline advantages of Peking University, strengthened cross-integration to facilitate the development of disciplines, promoted the reform of medical education and scientific research, and strived to improve infrastructure conditions.


Harbin Pharmaceutical Group has ranked first in the list of top 100 pharmaceutical industrial enterprises in China for five consecutive years. It owns 10 industrial enterprises such as Harbin Pharmaceutical General Factory and Sanjing Pharmaceutical, commercial circulation enterprises such as Renmin Tongtai and pharmaceutical research institutes. Harbin Pharmaceutical's products cover chemical raw materials and preparations, biological products, traditional Chinese medicine, health care products and pharmaceutical business sectors, and the brand value of "Harbin Pharmaceutical" reaches 26.216 billion yuan.


Baidu
sogou
bob最新官网- 官方(中国)有限公司 2022年世界杯官网【中国】有限公司 环球体育app官网中国有限公司 爱游戏·(中国)官方网站 华体汇体育官方网站(中国)股份有限公司 博鱼·体育(中国)官网
华体汇官网-华体汇(集团)管理有限公司